ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $267,057,600 | +0.4% | 9,840,000 | +13.8% | 0.61% | +4.8% |
Q2 2023 | $265,901,000 | +1.9% | 8,650,000 | +19.4% | 0.58% | -1.2% |
Q1 2023 | $261,032,558 | -5.6% | 7,244,867 | +3.5% | 0.58% | -11.6% |
Q4 2022 | $276,640,000 | -15.7% | 7,000,000 | -14.3% | 0.66% | -18.7% |
Q3 2022 | $328,070,000 | -53.3% | 8,165,000 | -51.1% | 0.81% | -49.4% |
Q2 2022 | $702,397,000 | -27.4% | 16,707,815 | -32.7% | 1.61% | -12.4% |
Q1 2022 | $967,872,000 | -2.2% | 24,842,715 | 0.0% | 1.84% | +3.1% |
Q4 2021 | $989,982,000 | +10.9% | 24,842,715 | +0.6% | 1.78% | +1.4% |
Q3 2021 | $892,579,000 | -4.2% | 24,697,815 | +8.7% | 1.76% | -3.6% |
Q2 2021 | $931,367,000 | -13.5% | 22,721,815 | -8.0% | 1.82% | -17.1% |
Q1 2021 | $1,076,880,000 | -44.4% | 24,687,756 | -36.2% | 2.20% | -47.9% |
Q4 2020 | $1,937,650,000 | +0.1% | 38,714,280 | -15.9% | 4.22% | -12.8% |
Q3 2020 | $1,935,865,000 | -13.3% | 46,015,330 | 0.0% | 4.85% | -15.3% |
Q2 2020 | $2,234,044,000 | – | 46,015,330 | – | 5.72% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
Brown University | 621,759 | $22,470,000 | 3.05% |
Graypoint LLC | 610,584 | $22,067,000 | 2.71% |